Published: February 16, 2026 at 8:17 am
The former CEO of SkinBioTherapeutics plc has been accused of misrepresenting results by the company’s board.
Stuart Ashman, who joined in 2024, was briefly suspended by the listed Newcastle firm last week and he resigned soon afterwards.
SkinBioTherapeutics said on Friday that it was investigating Ashman over ‘matters relating to his conduct’.
Now it says new information has given the board ‘reason to believe that the former CEO has misrepresented material information to the board and senior management, the company’s auditors and advisors’.